106 related articles for article (PubMed ID: 22040568)
1. Effect of human epididymis protein 4 gene silencing on the malignant phenotype in ovarian cancer.
Zou SL; Chang XH; Ye X; Cheng HY; Cheng YX; Tang ZJ; Zhang ZJ; Gao L; Chen XH; Cui H
Chin Med J (Engl); 2011 Oct; 124(19):3133-40. PubMed ID: 22040568
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional targeting in ovarian cancer cells using the human epididymis protein 4 promoter.
Berry NB; Cho YM; Harrington MA; Williams SD; Foley J; Nephew KP
Gynecol Oncol; 2004 Mar; 92(3):896-904. PubMed ID: 14984958
[TBL] [Abstract][Full Text] [Related]
3. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
4. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas.
Drapkin R; von Horsten HH; Lin Y; Mok SC; Crum CP; Welch WR; Hecht JL
Cancer Res; 2005 Mar; 65(6):2162-9. PubMed ID: 15781627
[TBL] [Abstract][Full Text] [Related]
5. Human epididymis protein 4 inhibits proliferation of human ovarian cancer cells via the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways.
Kong X; Chang X; Cheng H; Ma R; Ye X; Cui H
Int J Gynecol Cancer; 2014 Mar; 24(3):427-36. PubMed ID: 24557433
[TBL] [Abstract][Full Text] [Related]
6. HE4 in ovarian cancer: from discovery to clinical application.
Montagnana M; Danese E; Giudici S; Franchi M; Guidi GC; Plebani M; Lippi G
Adv Clin Chem; 2011; 55():1-20. PubMed ID: 22126021
[TBL] [Abstract][Full Text] [Related]
7. [HE4, a novel marker for epithelial ovarian cancer: evaluation of analytical performances].
Lamy PJ; Roques S; Viglianti C; Fabbro M; Montels F
Ann Biol Clin (Paris); 2010; 68(3):325-9. PubMed ID: 20478777
[TBL] [Abstract][Full Text] [Related]
8. [Effect of reduced expression of Her2 by RNA interference on the biological characters of ovarian carcinoma cells].
Wang KF; Cui H; Feng J; Yang R; Liang XD; Chang XH; Li Y; Cheng YX; Cheng HY; Ye X
Zhonghua Fu Chan Ke Za Zhi; 2008 Aug; 43(8):622-5. PubMed ID: 19087501
[TBL] [Abstract][Full Text] [Related]
9. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.
Moore RG; Brown AK; Miller MC; Skates S; Allard WJ; Verch T; Steinhoff M; Messerlian G; DiSilvestro P; Granai CO; Bast RC
Gynecol Oncol; 2008 Feb; 108(2):402-8. PubMed ID: 18061248
[TBL] [Abstract][Full Text] [Related]
10. Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women.
Holcomb K; Vucetic Z; Miller MC; Knapp RC
Am J Obstet Gynecol; 2011 Oct; 205(4):358.e1-6. PubMed ID: 21722869
[TBL] [Abstract][Full Text] [Related]
11. Effect of WFDC 2 silencing on the proliferation, motility and invasion of human serous ovarian cancer cells in vitro.
Zhu YF; Gao GL; Tang SB; Zhang ZD; Huang QS
Asian Pac J Trop Med; 2013 Apr; 6(4):265-72. PubMed ID: 23608327
[TBL] [Abstract][Full Text] [Related]
12. The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms.
Bingle L; Singleton V; Bingle CD
Oncogene; 2002 Apr; 21(17):2768-73. PubMed ID: 11965550
[TBL] [Abstract][Full Text] [Related]
13. [Measurement of serum human epididymis secretory protein 4 combined with CA125 assay in differential diagnosis of endometriosis cyst and ovarian benign and malignant tumors].
Liu YN; Ye X; Cheng HY; Cheng YX; Fu TY; Chen J; Chang XH; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2010 May; 45(5):363-6. PubMed ID: 20646446
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performances of HE4 and CA125 for the detection of ovarian cancer from patients with various gynecologic and non-gynecologic diseases.
Park Y; Lee JH; Hong DJ; Lee EY; Kim HS
Clin Biochem; 2011 Jul; 44(10-11):884-8. PubMed ID: 21549107
[TBL] [Abstract][Full Text] [Related]
15. The role of HE4 in ovarian cancer: inhibiting tumour cell proliferation and metastasis.
Gao L; Cheng HY; Dong L; Ye X; Liu YN; Chang XH; Cheng YX; Chen J; Ma RQ; Cui H
J Int Med Res; 2011; 39(5):1645-60. PubMed ID: 22117965
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
[TBL] [Abstract][Full Text] [Related]
17. Biological role and prognostic significance of NAC1 in ovarian cancer.
Nakayama K; Rahman MT; Rahman M; Yeasmin S; Ishikawa M; Katagiri A; Iida K; Nakayama N; Miyazaki K
Gynecol Oncol; 2010 Dec; 119(3):469-78. PubMed ID: 20869761
[TBL] [Abstract][Full Text] [Related]
18. [Effect of down-regulation of HE4 gene expression on biologic behavior of ovarian cancer cells].
Zhou L; Xiao R; Chen Y; Zhang J; Lu RQ; Guo L
Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):687-90. PubMed ID: 24433733
[TBL] [Abstract][Full Text] [Related]
19. Silencing of ZNF217 gene influences the biological behavior of a human ovarian cancer cell line.
Sun G; Zhou J; Yin A; Ding Y; Zhong M
Int J Oncol; 2008 May; 32(5):1065-71. PubMed ID: 18425333
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2 decreases cell proliferation and promotes accumulation of cells in S phase without affecting the rate of apoptosis in human ovarian carcinoma cells.
Bélanger S; Côté M; Lane D; L'Espérance S; Rancourt C; Piché A
Gynecol Oncol; 2005 Jun; 97(3):796-806. PubMed ID: 15913739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
